Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma
Yujia Xu, Min Xu, Jiefei Tong, et al.
Blood (2020) Vol. 137, Iss. 11, pp. 1478-1490
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis
Xue Han, Chune Ren, Chao Lü, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 9, pp. 1864-1873
Open Access | Times Cited: 56
OTUB1-mediated inhibition of ubiquitination: a growing list of effectors, multiplex mechanisms, and versatile functions
Miaomiao Wu, Lidong Sun, Tanjing Song
Frontiers in Molecular Biosciences (2024) Vol. 10
Open Access | Times Cited: 8
Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor?
Yihao Liao, Mengyue Yang, Keke Wang, et al.
Cancer Letters (2021) Vol. 526, pp. 248-258
Closed Access | Times Cited: 41
The role and regulation of Maf proteins in cancer
Yalan Deng, Liqing Lu, Huajun Zhang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis
Tong Sun, Yujia Xu, Shuoyi Jiang, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 8, pp. 1338-1346
Open Access | Times Cited: 49
The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein
Xinde Zhao, Ming Zhou, Yong Yang, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 12636-12645
Open Access | Times Cited: 34
Proteasomal inhibitors induce myeloma cell pyroptosis via the BAX/GSDME pathway
Jingpei Liang, Yuanming He, Yao‐Li Cui, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 7, pp. 1464-1474
Open Access | Times Cited: 15
TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation
Yuening Sun, Peng Lin, Xiumin Zhou, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 9, pp. 2803-2816
Open Access | Times Cited: 14
Targeting ZDHHC21/FASN axis for the treatment of diffuse large B-cell lymphoma
Bangdong Liu, Xianlan Zhao, S Zhang, et al.
Leukemia (2024) Vol. 38, Iss. 2, pp. 351-364
Open Access | Times Cited: 5
Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis
Shuoyi Jiang, Xiaoge Wang, Yuanming He, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 28
The functions and regulation of Otubains in protein homeostasis and diseases
Qiong Zhu, Yesheng Fu, Lei Li, et al.
Ageing Research Reviews (2021) Vol. 67, pp. 101303-101303
Closed Access | Times Cited: 27
OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination
Liqun Peng, Tiangen Wu, Yingyi Liu, et al.
Cellular Oncology (2024) Vol. 47, Iss. 3, pp. 987-1004
Open Access | Times Cited: 4
Induction of IFIT1/IFIT3 and inhibition of Bcl-2 orchestrate the treatment of myeloma and leukemia via pyroptosis
Yuanming He, Shuoyi Jiang, Yao‐Li Cui, et al.
Cancer Letters (2024) Vol. 588, pp. 216797-216797
Closed Access | Times Cited: 4
Rolapitant treats lung cancer by targeting deubiquitinase OTUD3
Tongde Du, Quan Gu, Yonghui Zhang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
OTUB1 promotes the progression of acute myeloid leukemia by regulating glycolysis via deubiquitinating c-Myc
Yang Liao, Liang Zhong, Yi Zhao, et al.
Cellular Signalling (2025) Vol. 131, pp. 111735-111735
Closed Access
OTUB1 inhibits breast cancer by non‐canonically stabilizing CCN6
Ying Zhao, Jing Ruan, Zhongding Li, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 10
The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes
Brendyn M. St. Louis, Sydney M. Quagliato, Yuting Su, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 3
Still high risk? A review of translocation t(14;16) in multiple myeloma
Hira Mian, Martin Kaiser, Rafaël Fonseca
American Journal of Hematology (2024) Vol. 99, Iss. 10, pp. 1979-1987
Closed Access | Times Cited: 3
Deubiquitinases as novel therapeutic targets for diseases
Yali Xian, Jing Ye, Yu Tang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 3
Deubiquitinases in hematological malignancies
Hu Lei, Jiaqi Wang, Jiacheng Hu, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis
Tong Sun, Yujia Xu, Zhuan Xu, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 21
Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer
Lingli Tan, Hengyue Shan, Chao Han, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 13645-13659
Closed Access | Times Cited: 14
Imaging-Based Screening of Deubiquitinating Proteases Identifies Otubain-1 as a Stabilizer of c-MYC
Shannon E. Moree, Laure Maneix, Polina Iakova, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 806-806
Open Access | Times Cited: 10
Targeting the oncogenic transcription factor c-Maf for the treatment of multiple myeloma
Qiuyun Jiang, Hongwu Mao, Guisong He, et al.
Cancer Letters (2022) Vol. 543, pp. 215791-215791
Closed Access | Times Cited: 10
Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia
Haixia Zhuang, Ying Ren, Chenyu Mao, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 9, pp. 102314-102314
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top